The efficacy and safety of tadalafil in the management of erectile dysfunction with diabetes and blood circulation issues

References

• International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021. Available from: https://diabetesatlas.org/
   Google Scholar
• Asaduzzaman M, Kamrul-Hasan AB, Islam A, et al. Frequency and risk factors of erectile dysfunction among Bangladeshi adult men with type 2 diabetes mellitus. Mymensingh Med J. 2020;29(1):66–72.
   PubMedGoogle Scholar
• Meyer MF, Pfohl M, Schatz H. Nachweis diabetischer ikrozirkulationsveranderungen mittels kapillaroskopie und Laser-doppler-Anemometrie. [Assessment of diabetic alterations of microcirculation by means of capillaroscopy and laser-Doppler anemometry]. Med Klin. 2001;96(2):71–77.
   Google Scholar
• Shabsigh R, Klein LT, Seidman S, et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology. 1998;52(5):848–852.
   PubMed Web of Science ®Google Scholar
• Giuseppe D, Rossella M, Marta T, et al. Erectile dysfunction and diabetes: a melting pot of circumstances and treatments. Diabetes Metab Res Rev. 2022;38(2):e3494.
   PubMed Web of Science ®Google Scholar
• Chu NV, Edelman SV. Diabetes and erectile dysfunction. Clin Diabetes. 2001;19(1):45–47.
   Google Scholar
• Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med. 2009;6(5):1232–1247.
   PubMed Web of Science ®Google Scholar
• Dolan NC, Liu K, Criqui MH, et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care. 2002;25(1):113–120.
   PubMed Web of Science ®Google Scholar
• Hatzichristou D, Haro JM, Martin-Morales A, et al. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the erectile dysfunction observational study. Int J Clin Pract. 2007;61(11):1850–1862.
   PubMed Web of Science ®Google Scholar
• Morano S. Pathophysiology of diabetic sexual dysfunction. J Endocrinol Invest. 2003;26(Suppl 3):65–69.
   PubMedGoogle Scholar
• Reffelmann T, Kieback A, Kloner RA. The cardiovascular safety of tadalafil. Expert Opin Drug Saf. 2008;7(1):43–52.
   PubMed Web of Science ®Google Scholar
• Falkensammer J, Hakaim AG, Falkensammer CE, et al. Prevalence of erectile dysfunction in vascular surgery patients. Vasc Med. 2007;12(1):17–22.
   PubMed Web of Science ®Google Scholar
• Vrsalovic M, Vucur K, Vrsalovic Presecki A, et al. Impact of diabetes on mortality in peripheral artery disease: a meta-analysis. Clin Cardiol. 2017;40(5):287–291.
   PubMed Web of Science ®Google Scholar
• Sáenz de Tejada I, Anglin G, Knight JR, et al. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care. 2002;25(12):2159–2164.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822–830.
   PubMed Web of Science ®Google Scholar
• Maldonado G, Guerrero R, Paredes C, et al. Nailfold capillaroscopy in diabetes mellitus. Microvasc Res. 2017;112:41–46.
   PubMed Web of Science ®Google Scholar
• Cutolo M, Sulli A, Secchi ME, et al. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology. 2006;45(Suppl 4):iv43–iv46.
   PubMedGoogle Scholar
• Cutolo M, Grassi W, Matucci Cerinic M. Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum. 2003;48(11):3023–3030.
   PubMedGoogle Scholar
• Wright AK, Kontopantelis E, Emsley R, et al. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation. 2019;139(24):2742–2753.
   PubMed Web of Science ®Google Scholar
• Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–78.
   PubMed Web of Science ®Google Scholar
• Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383(9933):1973–1980.
   PubMed Web of Science ®Google Scholar
• Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542–1551.
   PubMed Web of Science ®Google Scholar
• Cosentino F, Ceriello A, Baeres FMM, et al. Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable. Eur Heart J. 2019;40(34):2907–2919.
   PubMed Web of Science ®Google Scholar
• Bocchio M, Pelliccione F, Passaquale G, et al. Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. Atherosclerosis. 2008;196(1):313–319.
   PubMed Web of Science ®Google Scholar
• Rosano GM, Aversa A, Vitale C, et al. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol. 2005;47(2):214–220. discussion 220–222.
   PubMed Web of Science ®Google Scholar
• Vilela VR, de Oliveira AL, Comar JF, et al. Tadalafil inhibits the cAMP stimulated glucose output in the rat liver. Chem Biol Interact. 2014;220:1–11.
   PubMed Web of Science ®Google Scholar
• Wang J, Li J, Ren Y, et al. Association between alanine aminotransferase/aspartate aminotransferase ratio (AST/ALT ratio) and coronary artery injury in children with Kawasaki disease. Cardiol Res Pract. 2020;2020:8743548.
   PubMed Web of Science ®Google Scholar
• Hur KY. Diagnosis of peripheral artery disease: focus on the 2016 American Heart Association/American College of Cardiology and 2017 European Society of Cardiology guidelines. J Korean Diabetes. 2019;20(1):17–23.
   Google Scholar
• Mueller T, Hinterreiter F, Poelz W, et al. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med. 2016;21(5):445–452.
   PubMed Web of Science ®Google Scholar
• Meena BL, Kochar DK, Agarwal TD, et al. Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease. Int J Diabetes Dev Ctries. 2009;29(4):150–154.
   PubMed Web of Science ®Google Scholar
• Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition examination survey, 1999–2000. Circulation. 2004;110(6):738–743.
   PubMed Web of Science ®Google Scholar
• Polonsky TS, Taillon LA, Sheth H, et al. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009;207(2):440–444.
   PubMed Web of Science ®Google Scholar
• Petrofsky JS, Berk L, Alshammari F, et al. The interrelationship between air temperature and humidity as applied locally to the skin: the resultant response on skin temperature and blood flow with age differences. Med Sci Monit. 2012;18(4):CR201–8.
   PubMed Web of Science ®Google Scholar
• Mohamed A, Ismail A. Erectile dysfunction: the non-utilized role of exercise rehabilitation for the most embarrassing forgotten post-COVID complication in men. Aging Male. 2022;25(1):217–218.
   PubMed Web of Science ®Google Scholar
• Adeyemi DH, Odetayo AF, Hamed MA, et al. Impact of COVID 19 on erectile function. Aging Male. 2022;25(1):202–216.
   PubMed Web of Science ®Google Scholar